Brand Manager Gastroenterology at Eli Lilly and Company

Brussels, Brussels, Belgium

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Ability to embrace an external focus: Understand the gastroenterology market landscape, competitive development efforts, and needs of patients, caregivers, physicians, and payers in Belgium
Active participation with medical in defining and implementing Thought Leader action plans and contacts; being connected with gastroenterologists
Gather external market and customer insights to tailor the Gastroenterology community strategy into local Belgian implementation
Collaborate with Patient Advocacy Groups (PAGs) in their educational role
Capacity to engage internal team as a catalyst: Work closely with regional marketing partners in the Gastroenterology community to deliver insights and act as interface between the community and Belgian affiliate
Effectively develop cross-functional relationships with local Marketing & Medical, PRA, Sales, Medical Shared Services, and Ethics & Compliance
Respect Lilly and local standards with a proactive approach to guidance and compliance
Create and implement comprehensive cross-functional business/customer plans using EU Therapeutic Area community brand plan as basis
Integrate customer insights into Key Player Objectives and major tactics, optimizing channel mix
Ensure tactical implementation adds value to customers (HCP, caregiver, patient) and monitor execution to adjust strategy as needed

Responsibilities

Develop, drive, and execute customer/brand plans to ensure product uptake/growth and unparalleled customer experience in BeLux gastroenterology portfolio
Combine customer-facing activities with collaboration at local (PRA, medical, sales) and regional (Gastroenterology community) levels
Lead the Brand/Customer team
Enable successful access and reimbursement through close collaboration with local PRA
Engage Sales Reps using Customer Dialogue Model (get input, enhance materials, transfer with ambassadors) via strong communication
Reassure gastroenterology commercialization strategies are embedded into local plans by communicating and influencing stakeholders
Frequently monitor customer plan execution and customer-facing activities (e.g., Lilly Listens) to emphasize or change strategy if needed

Skills

Brand Management

Marketing Strategy

Market Analysis

Customer Insights

Thought Leadership

Stakeholder Engagement

Patient Advocacy

Gastroenterology

Pharmaceutical Marketing

Sales Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free